Anti-TERT/ CMM9/ DKCA2 monoclonal antibody

Anti-TERT/ CMM9/ DKCA2 antibody for FACS & in-vivo assay

Target products collectionGo to TERT/TERT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T86052-Ab-1/ GM-Tg-hg-T86052-Ab-2Anti-Human TERT monoclonal antibodyHuman
GM-Tg-rg-T86052-Ab-1/ GM-Tg-rg-T86052-Ab-2Anti-Rat TERT monoclonal antibodyRat
GM-Tg-mg-T86052-Ab-1/ GM-Tg-mg-T86052-Ab-2Anti-Mouse TERT monoclonal antibodyMouse
GM-Tg-cynog-T86052-Ab-1/ GM-Tg-cynog-T86052-Ab-2Anti-Cynomolgus/ Rhesus macaque TERT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T86052-Ab-1/ GM-Tg-felg-T86052-Ab-2Anti-Feline TERT monoclonal antibodyFeline
GM-Tg-cang-T86052-Ab-1/ GM-Tg-cang-T86052-Ab-2Anti-Canine TERT monoclonal antibodyCanine
GM-Tg-bovg-T86052-Ab-1/ GM-Tg-bovg-T86052-Ab-2Anti-Bovine TERT monoclonal antibodyBovine
GM-Tg-equg-T86052-Ab-1/ GM-Tg-equg-T86052-Ab-2Anti-Equine TERT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T86052-Ab-1/ GM-Tg-hg-T86052-Ab-2; GM-Tg-rg-T86052-Ab-1/ GM-Tg-rg-T86052-Ab-2;
GM-Tg-mg-T86052-Ab-1/ GM-Tg-mg-T86052-Ab-2; GM-Tg-cynog-T86052-Ab-1/ GM-Tg-cynog-T86052-Ab-2;
GM-Tg-felg-T86052-Ab-1/ GM-Tg-felg-T86052-Ab-2; GM-Tg-cang-T86052-Ab-1/ GM-Tg-cang-T86052-Ab-2;
GM-Tg-bovg-T86052-Ab-1/ GM-Tg-bovg-T86052-Ab-2; GM-Tg-equg-T86052-Ab-1/ GM-Tg-equg-T86052-Ab-2
Products NameAnti-TERT monoclonal antibody
Formatmab
Target NameTERT
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TERT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TERT/ CMM9/ DKCA2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAD000402human TERT Adenovirus plasmid
    ORF Viral VectorvGMLV000557human TERT Lentivirus particle
    ORF Viral VectorvGMLV000364human TERT Lentivirus particle
    ORF Viral VectorvGMAD000402human TERT Adenovirus particle
    ORF Viral VectorpGMLV000364human TERT Lentivirus plasmid
    ORF Viral VectorpGMLV000557human TERT Lentivirus plasmid
    ORF Viral VectorvGMLV000884human TERT Lentivirus particle
    ORF Viral VectorpGMLV000009human TERT Lentivirus plasmid
    ORF Viral VectorpGMLV000884human TERT Lentivirus plasmid
    ORF Viral VectorvGMLV000009human TERT Lentivirus particle
    ORF Viral VectorpGMAD000360rat Tert Adenovirus plasmid
    ORF Viral VectorpGMAD000476Norway rat Tert Adenovirus plasmid
    ORF Viral VectorvGMAD000360rat Tert Adenovirus particle
    ORF Viral VectorvGMAD000476Norway rat Tert Adenovirus particle


    Target information

    Target IDGM-T86052
    Target NameTERT
    Gene ID7015,21752,301965,709865,403412,100144612,518884,100630695
    Gene Symbol and SynonymsCMM9,DKCA2,DKCB4,EST2,hEST2,hTRT,PFBMFT1,TCS1,TERT,TP2,TR,TRT
    Uniprot AccessionO14746,Q673L6,Q6A548,Q27ID4
    Uniprot Entry NameTERT_HUMAN,TERT_RAT,TERT_CANLF,TERT_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseCancer
    Gene EnsemblENSG00000164362
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: TERT, gene name: TERT, also named as CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT. Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.